Amrize Ltd $AMRZ Stock Sold by Bryn Mawr Trust Advisors LLC

Bryn Mawr Trust Advisors LLC trimmed its position in Amrize Ltd (NYSE:AMRZ) by 48.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,640 shares of the company’s stock after selling 75,714 shares during the period. Bryn Mawr Trust Advisors LLC’s holdings in Amrize were worth $2,978,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Continuum Advisory LLC bought a new position in shares of Amrize during the second quarter worth $62,000. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Amrize in the 3rd quarter valued at $49,000. IFP Advisors Inc increased its position in shares of Amrize by 1,707.3% in the 3rd quarter. IFP Advisors Inc now owns 1,988 shares of the company’s stock valued at $74,000 after buying an additional 1,878 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Amrize by 1,419.7% in the 2nd quarter. NewEdge Advisors LLC now owns 2,082 shares of the company’s stock valued at $111,000 after buying an additional 1,945 shares in the last quarter. Finally, Oslo Pensjonsforsikring AS acquired a new stake in Amrize during the 1st quarter worth $133,000.

Insider Activity at Amrize

In other Amrize news, Director Jacques Sanche bought 4,150 shares of Amrize stock in a transaction that occurred on Wednesday, August 26th. The stock was acquired at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the acquisition, the director owned 9,766 shares of the company’s stock, valued at $439,665.32. This trade represents a 73.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Jan Jenisch bought 26,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was acquired at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the transaction, the chief executive officer owned 1,767,000 shares of the company’s stock, valued at $75,044,490. This represents a 1.49% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 34,155 shares of company stock valued at $1,461,276 over the last ninety days. Company insiders own 0.54% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Citigroup reduced their target price on Amrize from $58.00 to $50.00 and set a “buy” rating on the stock in a report on Friday, October 2nd. Wells Fargo & Company cut their price objective on Amrize from $40.00 to $39.00 and set an “equal weight” rating on the stock in a report on Friday, October 30th. Sanford C. Bernstein reissued an “outperform” rating and set a $60.00 target price on shares of Amrize in a research note on Monday, September 21st. Oppenheimer cut their price target on shares of Amrize from $55.00 to $52.00 and set an “outperform” rating on the stock in a research note on Monday, November 2nd. Finally, Berenberg Bank cut shares of Amrize from a “buy” rating to a “hold” rating and reduced their price target for the company from $48.00 to $46.00 in a report on Monday. Eight analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $47.65.

Amrize Stock Up 2.7%

AMRZ stock opened at $42.98 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67. The stock has a market capitalization of $23.77 billion, a P/E ratio of 19.45, a P/E/G ratio of 1.73 and a beta of 0.04. The business has a 50-day moving average of $39.49 and a 200-day moving average of $50.25. Amrize Ltd has a fifty-two week low of $35.78 and a fifty-two week high of $65.94.

Amrize (NYSE:AMRZ) last announced its earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.05. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The business had revenue of $3.77 billion for the quarter. During the same period in the prior year, the business posted $0.98 EPS. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Amrize Ltd will post 2.30 earnings per share for the current fiscal year.

Amrize Dividend Announcement

The firm also recently declared a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s dividend payout ratio (DPR) is currently 4.98%.

Amrize Company Profile

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets.

The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects.

Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.